AstraZeneca Pharma IndiaASTRAZEN 
$81.06-0.41%24h
-0.41%24h
Global rank5132
Market cap$2.03B
Change 7d-4.10%
YTD Performance23.63%
SP500 benchmarkOutperform
P/E2.04
P/S16.95
Revenue$119.57M
Earnings$11.84M
Dividend yield-
Main Sector
Healthcare
Category
AstraZeneca Pharma India (ASTRAZEN) Cash on Hand
ASTRAZEN Cash on Hand in 2022: $60.92M
According to AstraZeneca Pharma India latest financial reports the cash on hand of ASTRAZEN is $60.92M, an increase of 10.92% to 2022. At the end of 2022 company had $54.92M cash on hand. This amount reflects the liquid assets available to the company, which are crucial for its operational flexibility, investment opportunities, and overall financial security.
ASTRAZEN Cash on Hand History from 2019 to 2023
-
Value:-
ASTRAZEN Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023 | $60.92M | 10.92% |
| 2022 | $54.92M | 28.70% |
| 2021 | $42.68M | 41.78% |
| 2020 | $30.10M | 45.75% |
| 2019 | $20.65M | - |
View the Top Cash on Hand Companies 
